viru
evolv
rapidli
escap
vaccineinduc
immun
pose
desper
demand
effici
vaccin
develop
biotechnolog
present
express
vaccin
develop
strategi
base
crelox
system
reemerg
pseudorabi
viru
caus
recent
devast
swine
pseudorabi
outbreak
china
system
virul
gene
newli
isol
strain
simultan
substitut
marker
gene
subsequ
excis
use
crelox
system
vaccin
safeti
concern
notabl
singl
cell
fac
technolog
appli
promot
viru
purif
effici
combin
stateofart
technolog
greatli
acceler
vaccin
develop
final
vaccin
challeng
experi
prove
vaccin
candid
protect
efficaci
pig
promis
control
current
pseudorabi
outbreak
knowledg
first
success
vaccin
develop
base
gene
edit
technolog
demonstr
technolog
leap
laboratori
industri
may
pave
way
futur
express
antivir
vaccin
develop
infecti
diseas
caus
novel
emerg
reemerg
virus
pose
continu
threat
health
economi
vaccin
effect
way
prevent
viral
infecti
diseas
save
million
live
everi
year
yet
current
long
labori
journey
develop
antivir
vaccin
ineffici
challengingli
viru
evolv
rapidli
escap
old
vaccineinduc
immun
chang
genom
architect
therefor
new
biotechnolog
facilit
acceler
vaccin
develop
novel
emerg
reemerg
virus
desper
need
endless
arm
race
dynam
evolv
viru
although
genom
dna
virus
rel
stabl
rna
virus
mani
studi
report
outbreak
infecti
diseas
caus
reemerg
dna
viru
adenoviru
herp
simplex
viru
hsv
chicken
pox
viru
varicella
hepat
b
viru
hbv
cytomegaloviru
cmv
etc
recent
pseudorabi
viru
prv
model
herp
viru
wide
preval
vaccin
pig
farm
china
caus
tremend
econom
loss
swine
industri
prv
member
alpha
herpesvirina
subfamili
constitut
approxim
k
doubl
strand
dna
genom
prv
infect
caus
pseudorabi
one
devast
swine
infecti
diseas
swine
industri
worldwid
well
control
decad
use
attenu
gene
delet
vaccin
howev
spite
great
effort
prv
vaccin
pseudorabi
reemerg
one
top
swine
epidem
diseas
recent
time
like
due
prv
mutat
caus
antigen
drift
conceiv
phenomenon
occur
entir
viru
commun
labori
timeconsum
tradit
vaccin
develop
strategi
includ
attenu
vaccin
gene
delet
vaccin
requir
mani
round
plaqu
purif
passag
meet
urgent
demand
new
vaccin
develop
inactiv
vaccin
much
faster
requir
high
dose
administr
gener
less
effect
thu
imper
need
novel
technolog
could
speed
simplifi
vaccin
develop
recent
revolutionari
geneedit
technolog
term
cluster
regularli
interspac
palindrom
repeat
crispr
associ
system
provid
versatil
tool
gene
edit
guid
rna
grna
mutant
protein
specif
break
nick
target
dna
high
effici
subsequ
caus
indel
target
region
nonhomolog
end
join
nhej
dna
damag
repair
foreign
gene
knockedin
homolog
recombin
hr
presenc
homolog
dna
donor
two
pathway
deliber
manipul
gene
edit
purpos
differ
organ
howev
technolog
gene
edit
dna
virus
infanc
evid
system
appli
gene
edit
dna
virus
hsv
prv
adenoviru
hbv
yet
technolog
neither
demonstr
simultan
multigen
delet
viral
genom
success
vaccin
develop
crelox
system
anoth
high
effici
technolog
extens
use
gene
manipul
mani
speci
lox
site
deriv
bacteriophag
contain
sever
variant
specif
selfcompat
lox
p
lox
n
lox
togeth
applic
modern
power
technolog
may
potenti
acceler
vaccin
develop
aim
present
studi
therefor
isol
reemerg
prv
use
model
viru
establish
fast
costeffect
technolog
express
vaccin
develop
isol
character
sequenc
analysi
reemerg
prv
virul
strain
sinc
prv
reemerg
escap
old
vaccineinduc
immun
caus
widespread
pseudorabi
outbreak
vaccin
pig
farm
china
order
isol
new
prv
virul
variant
resist
current
vaccin
prvpcrposit
brain
sampl
abort
fetu
vaccin
pig
homogen
inocul
onto
cell
bacteria
filter
new
prv
virul
strain
hnx
isol
plaqu
purif
major
antigen
glycoprotein
b
gb
gc
gd
prv
amplifi
pcr
subject
sequenc
shown
fig
c
gb
gc
gd
amino
acid
sequenc
prv
hnx
display
variat
delet
compar
bartha
strain
previou
pandem
ea
strain
character
virul
prv
hnx
strain
prvfree
piglet
intramascularli
vaccin
classic
attenu
live
vaccin
challeng
prv
hnx
ea
strain
group
challeng
prv
hnx
strain
develop
typic
pseudorabi
symptom
wherea
symptom
observ
ea
uninfect
control
group
data
shown
confirm
fever
rectal
temperatur
prv
hnx
infect
group
prv
ea
infect
uninfect
control
group
fig
moreov
viru
neutral
titer
antisera
measur
day
vaccin
compar
neutral
titer
antisera
prv
ea
titer
prv
hnx
significantli
lower
suggest
insuffici
prophylact
effect
vaccin
reemerg
prv
hnx
strain
fig
collect
data
demonstr
reemerg
prv
strain
escap
immun
induc
current
commerci
vaccin
thu
pose
urgent
demand
new
vaccin
prv
multivirul
gene
recombin
via
system
establish
express
vaccin
develop
strategi
two
highli
effici
gene
edit
system
crelox
system
employ
meanwhil
singl
cell
fac
techniqu
also
appli
simplifi
acceler
plaqu
purif
shown
fig
avoid
fals
posit
signal
caus
fluoresc
gene
express
homolog
recombin
donor
templat
express
gfp
mcherri
driven
endogen
viral
promot
occur
precis
dna
homolog
recombin
gfp
mcherri
gene
flank
lox
p
lox
n
pair
respect
facilit
fluoresc
marker
gene
excis
fig
thymidin
kinas
tk
ge
major
virul
gene
prv
also
primari
target
prv
gene
delet
vaccin
simultan
delet
tk
ge
gene
achiev
system
mediat
homolog
recombin
firstli
sgrna
target
tk
ge
gene
design
web
base
tool
http
crisprmitedu
dna
donor
contain
fluoresc
select
gene
homolog
arm
cotransfect
cell
fig
eight
hour
post
transfect
cell
infect
prv
hnx
differ
moi
multipl
infect
incub
recombin
viru
express
red
andor
green
fluoresc
observ
fig
notabl
greenr
overlap
cell
observ
control
group
data
shown
next
recombin
virus
collect
inocul
cell
cell
fluoresc
subject
fac
plate
one
cell
per
well
plate
precultur
cell
well
show
maximum
green
red
overlap
signal
subject
one
round
plaqu
purif
obtain
pure
recombin
virus
fig
virus
tk
gene
replic
much
faster
may
thu
outgrow
tk
gene
delet
virus
appli
bvdu
bromovinyl
deoxyuridin
inhibitor
tk
suppress
wt
prv
ge
singl
delet
prv
final
puriti
recombin
viru
valid
pcr
amplif
shown
fig
posit
control
pcr
band
observ
sampl
except
h
excis
doubl
fluoresc
marker
gene
via
crelox
base
system
due
vaccin
safeti
concern
regul
select
marker
vaccin
candid
need
complet
remov
end
incompat
loxp
loxn
site
insert
homolog
recombin
dna
donor
flank
gfp
mchrrey
gene
respect
orient
fig
cell
use
cre
recombinas
gene
transfect
mediat
gene
excis
high
transfect
express
effici
cell
line
shown
fig
cre
recombinas
gene
transfect
cell
infect
prvhnxtk
ge
gfp
mcherri
recombin
prv
variou
moi
hour
incub
cre
recombinas
transfect
cell
exhibit
signific
less
fluoresc
compar
control
mock
transfect
fig
c
first
gener
cretreat
recombin
virus
harvest
infect
moi
show
highest
effici
gene
excis
doubl
fluoresc
gene
excis
achiev
three
round
plaqu
purif
shown
fig
thu
virtu
genomeedit
tool
reemerg
prv
hnx
success
engin
prvhnxtk
ge
recombin
viru
prophylact
effect
prvhnxtk
ge
mice
piglet
safeti
novel
vaccin
candid
firstli
assess
mice
mice
inject
prv
hnx
group
die
three
five
day
later
wherea
prvhnxtk
ge
inject
mice
remain
healthi
fig
next
prvhnxtk
ge
vaccin
mice
challeng
reemerg
prv
hnx
prv
ea
standard
wt
viru
strain
prvbecker
gfp
ge
posit
fig
demonstr
vaccin
prvhnxtk
ge
provid
complet
protect
previou
reemerg
prv
strain
support
presenc
extens
gfp
signal
brain
section
unvaccin
mice
vaccin
group
fig
next
sixteen
prvfree
piglet
randomli
divid
two
group
one
group
immun
prvhnxtk
ge
dmem
subsequ
challeng
current
pandem
prv
intranas
day
post
vaccin
death
antigb
antibodi
clinic
sign
includ
bodi
temperatur
respiratori
distress
depress
anorexia
cough
convuls
ataxia
itch
weight
measur
record
typic
pseudorabi
clinic
sign
observ
prvhnxtk
ge
vaccin
group
wherea
sever
pseudorabi
symptom
develop
control
group
data
shown
shown
fig
vaccin
candid
complet
protect
piglet
current
pandem
prv
strain
two
piglet
surviv
control
group
line
antigb
antibodi
significantli
increas
post
vaccin
vaccin
piglet
fig
fever
rectal
temperatur
daili
weight
gain
vaccin
group
significantli
control
group
fig
next
dead
surviv
piglet
subject
histopatholog
analysi
piglet
control
group
exhibit
sever
patholog
damag
brain
obviou
mening
inflamm
microglia
nodul
perivascular
cuff
wherea
mild
mening
inflamm
observ
vaccin
piglet
even
challeng
high
dose
viru
fig
f
togeth
data
demonstr
potenti
vaccin
candid
protect
pseudorabi
despit
interdisciplinari
effort
still
timeconsum
labori
develop
vaccin
constantli
chang
virus
studi
isol
reemerg
prv
use
model
establish
fast
costeffect
technolog
express
vaccin
develop
tradit
way
develop
multipl
gene
delet
vaccin
involv
sever
step
singl
gene
recombin
marker
gene
excis
obtain
prv
doubl
gene
delet
vaccin
candid
requir
twenti
round
timeconsum
plaqu
purif
combin
two
highli
effici
gene
edit
system
crispr
system
crelox
system
increas
multigen
edit
effici
viral
genom
meanwhil
singl
cell
fac
technolog
also
employ
promot
viru
purif
effici
inde
obtain
prvhnxtk
ge
gfp
mcherri
recombin
prv
singl
round
plaqu
purif
wherea
requir
ten
round
plaqu
purif
tradit
strategi
moreov
own
high
effici
cre
recombinas
incompat
loxp
loxn
site
multipl
marker
gene
excis
achiev
simultan
one
step
follow
three
round
plaqu
purif
note
studi
express
select
fluoresc
gene
driven
endogen
viral
promot
occur
precis
dna
homolog
recombin
scenario
could
avoid
fals
posit
due
basal
fluoresc
gene
express
thu
util
singl
cell
sort
updat
tradit
timeconsum
viral
plaqu
purif
togeth
strategi
greatli
facilit
acceler
prv
vaccin
develop
simpli
one
step
simultan
multiplegen
recombin
mediat
system
one
step
simultan
multipl
marker
gene
excis
mediat
crelox
system
requir
four
round
plaqu
purif
total
obtain
doubl
gene
delet
vaccin
candid
strategi
could
also
appli
vaccin
develop
dna
viru
hsv
cmv
adenoviru
vzv
duck
hepat
viru
dhv
bovin
herpesviru
bhv
epstein
barr
viru
ebv
yet
system
mostli
appli
dna
edit
accumul
data
suggest
versatil
technolog
could
also
work
effect
rna
world
oconnel
et
al
demonstr
transcomplement
protospac
adjac
motif
present
oligonucleotid
pammer
inde
stimul
sitespecif
target
cleavag
ssrna
endonucleas
recent
francisella
novicida
shown
capabl
target
endogen
bacteri
rna
engin
target
inhibit
hepat
c
viru
ssrna
viru
conceiv
advanc
dynam
research
field
crisprca
system
could
possibl
employ
develop
antirna
viru
vaccin
moreov
recombin
prv
hsv
extens
exploit
neural
circuit
trace
strategi
could
also
significantli
simplifi
recombin
viral
tracer
engin
could
thu
contribut
neurosci
research
well
shown
crispr
system
use
viral
genom
edit
applic
technolog
virus
infanc
crisprbas
simultan
multipl
viral
gene
edit
vaccin
develop
never
report
simultan
replac
two
main
virul
prv
gene
ge
tk
gfp
mcherri
respect
use
system
assist
homolog
recombin
contrari
recent
studi
show
system
could
work
extract
prv
viral
genom
dna
data
prove
system
also
abl
directli
edit
prv
genom
viral
infect
line
report
crispr
system
introduc
host
cell
adenoviru
hsv
replic
inde
robustli
stimul
dna
breakag
target
genom
high
frequenc
discrep
could
possibl
due
applic
tk
gene
inhibitor
experi
prevent
wt
virus
outgrow
gene
delet
virus
gener
genom
dna
virus
rel
stabl
rna
virus
howev
mani
studi
report
outbreak
infecti
diseas
caus
newli
reemerg
dna
virus
isol
reemerg
prv
hnx
resist
classic
prv
vaccin
sequenc
analysi
reveal
sever
mutationsdelet
gb
gc
gd
prv
would
great
interest
investig
whether
mutationsdelet
could
caus
antigen
drift
molecular
mechan
lead
resist
vaccin
induc
immun
swine
popul
anim
experi
mous
piglet
valid
protect
effect
gene
edit
technolog
base
new
vaccin
candid
demonstr
potenti
control
current
pseudorabi
outbreak
swine
industri
togeth
combin
sever
stateofart
modern
biotechnolog
establish
novel
strategi
express
vaccin
develop
obtain
knowledg
first
success
gene
edit
technolog
base
vaccin
candid
new
gener
biotechnolog
base
strategi
might
open
express
avenu
futur
antivir
vaccin
develop
plasmid
construct
viral
genom
prepar
pcr
amplif
guid
rna
clone
express
vector
addgen
plasmid
previous
describ
ge
tk
homolog
arm
amplifi
prv
hnx
strain
pcr
donor
templat
construct
use
overlap
pcr
gfp
insert
ge
posit
prvbecker
bac
kind
gift
dr
l
w
enquist
viru
rescu
cell
previous
describ
prv
genom
dna
extract
use
tianamp
viru
dna
kit
tiangen
follow
manufactur
protocol
sequenc
primer
sgrna
donor
templat
antigen
gene
list
supplementari
data
dmem
fb
streptomycinpenicillin
dna
transfect
cell
use
lipofectamin
prv
infect
perform
previous
describ
cultur
medium
chang
dmem
fb
transfect
viral
infect
dna
synthesi
sequenc
analysi
pcr
primer
synthesi
dna
sequenc
done
shanghai
sangon
biotch
china
gb
gc
gd
gene
sequenc
prv
ea
strain
obtain
ncbi
analyz
bioedit
softwar
viru
prepar
propag
plaqu
purif
viru
infect
cell
harvest
hour
postinfect
three
round
freezethaw
cell
lysat
centrifug
minut
rpmmin
supernat
use
next
propag
store
viru
purif
infect
cell
cover
mixtur
dmem
low
meltingpoint
agaros
g
ml
bvdu
necessari
hour
wellsepar
plaqu
pick
pipett
tip
pipet
microtub
contain
l
serum
free
dmem
next
propag
plaqu
purif
fluorescenceactiv
cell
sort
fluorescenceactiv
cell
sort
perform
moflo
xdp
sorter
beckman
coulter
follow
manufactur
protocol
cell
infect
first
gener
recombin
prv
moi
singl
cell
express
fluoresc
protein
sort
plate
preseed
cell
anim
experi
femal
balbc
mice
immun
prvhnx
tk
ge
inocul
subcutan
prv
hnx
prv
ea
prv
becker
two
week
later
piglet
experi
prvhnx
tk
ge
prv
inject
intramuscularli
immun
booster
vaccin
perform
day
later
piglet
intranas
challeng
prv
day
post
second
immun
clinic
sign
record
daili
day
anim
experi
approv
research
ethic
committe
huazhong
agricultur
univers
hubei
china
anim
experi
carri
accord
recommend
guid
care
use
laboratori
anim
research
ethic
committe
huazhong
agricultur
univers
hubei
china
elisa
neutral
assay
histopatholog
serum
sampl
prvspecif
gb
antibodi
evalu
use
commerci
elisa
kit
accord
manufactur
direct
idexx
usa
neutral
antibodi
prv
test
describ
previous
brain
tissu
fix
paraformaldehyd
solut
room
temperatur
day
process
routin
histopatholog
procedur
previous
describ
